Wong Vincent, Hashemipour Reza, Manoharan Anjella, Ahlawat Sushil
Internal Medicine-Pediatrics, Rutgers University New Jersey Medical School, Newark, USA.
Gastroenterology and Hepatology, Rutgers University New Jersey Medical School, Newark, USA.
Cureus. 2022 Oct 15;14(10):e30319. doi: 10.7759/cureus.30319. eCollection 2022 Oct.
Introduction Paralytic ileus (PI) is often seen in critically ill hospitalized patients. Those with pancreaticobiliary diseases will require endoscopic retrograde cholangiopancreatography (ERCP) for management. Here, we will explore the association between patients with paralytic ileus who underwent ERCP and post-procedural complications, which has not been done before. Methods Patients who underwent ERCP between 2007 and 2017 in the National Inpatient Sample database were selected. Cases were matched 1:1 by age, gender, race, and the Elixhauser comorbidity index for patients with and without pre-procedural paralytic ileus. Primary outcomes were associations between paralytic ileus and length of stay, payor status, and average total charges. Secondary outcomes were associations between paralytic ileus and post-ERCP complications (infection, pancreatitis, cholangitis, cholecystitis, perforation, hemorrhage), and overall mortality. The Chi-squared analysis was used to compare categorical data, and the independent t-test was used for continuous data. Regression analysis was used to assess primary and secondary outcomes. Results Of 2,008,217 hospitalized patients from 2007 to 2017, 43,643 patients had paralytic ileus and 43,859 patients did not, before undergoing ERCP. There were no differences in age, gender, race, or the Elixhauser comorbidity index. The differences in the length of stay, payor status, and total charges were significant (p<0.001). Patients with paralytic ileus had increased risks of post-ERCP infection, pancreatitis, cholangitis, cholecystitis, perforation, hemorrhage, and overall mortality (p<0.001). Conclusions Patients hospitalized with paralytic ileus who underwent ERCP had a longer length of stay, higher total charges, and were less compensable. They also had increased risks for post-ERCP infection, pancreatitis, cholangitis, cholecystitis, perforation, hemorrhage, and overall mortality, which can be from critical illness and the systemic inflammatory response.
引言
麻痹性肠梗阻(PI)在危重症住院患者中较为常见。患有胰胆疾病的患者需要接受内镜逆行胰胆管造影术(ERCP)进行治疗。在此,我们将探讨接受ERCP的麻痹性肠梗阻患者与术后并发症之间的关联,此前尚未有过此类研究。
方法
选取2007年至2017年期间在国家住院样本数据库中接受ERCP的患者。按照年龄、性别、种族以及埃利克斯豪泽合并症指数,将有术前麻痹性肠梗阻和无术前麻痹性肠梗阻的患者进行1:1匹配。主要结局是麻痹性肠梗阻与住院时间、支付者状态和平均总费用之间的关联。次要结局是麻痹性肠梗阻与ERCP术后并发症(感染、胰腺炎、胆管炎、胆囊炎、穿孔、出血)以及总体死亡率之间的关联。采用卡方分析比较分类数据,采用独立t检验分析连续数据。使用回归分析评估主要和次要结局。
结果
在2007年至2017年的2,008,217例住院患者中,43,643例患者在接受ERCP前患有麻痹性肠梗阻,43,859例患者未患。在年龄、性别、种族或埃利克斯豪泽合并症指数方面无差异。住院时间、支付者状态和总费用方面的差异具有统计学意义(p<0.001)。患有麻痹性肠梗阻的患者术后发生感染、胰腺炎、胆管炎、胆囊炎、穿孔、出血及总体死亡的风险增加(p<0.001)。
结论
接受ERCP的麻痹性肠梗阻住院患者住院时间更长、总费用更高且可补偿性更低。他们发生ERCP术后感染、胰腺炎、胆管炎、胆囊炎、穿孔、出血及总体死亡的风险也增加,这可能源于危重症和全身炎症反应。